JAK1 pathway inhibitors for the treatment of vitiligo Grant US-11957661-B2 United States of America 16 Apr 2024
Sustained-release dosage forms of ruxolitinib Grant US-11896717-B2 United States of America 13 Feb 2024
Tricyclic fused thiophene derivatives as JAK inhibitors Grant US-11851442-B2 United States of America 26 Dec 2023